-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeUSDISIN US5324571083-
Eli Lilly and CoBörse NYSE New York Stock ExchangeISIN US5324571083USDSymbol LLY-WD
-
Eli LillyBörse Börse StuttgartISIN XS1240751229EURSymbol LLY
-
Eli Lilly and CompanyBörse Xetra FrankfurtISIN US532457BV93EURSymbol LLY
-
ELI LILLY & COBörse Börse BerlinISIN XS1240751062EURSymbol LLY
-
ELI LILLY & COBörse Börse HamburgISIN XS2075937370EURSymbol LLY
-
ELI LILLY & COBörse Gettex System der Börse MünchenISIN US532457BS64EURSymbol LLY
-
ELI LILLY & COBörse Quotrix System der Börse DüsseldorfISIN XS1240750767EURSymbol LLY
-
ELI LILLY & COBörse Tradegate System der Deutsche Börse AG (60%)ISIN US532457BR81EURSymbol LLY
-
ELI LILLY & COBörse Börse DüsseldorfISIN US532457AZ17EURSymbol LLY
-
ELI LILLY & COBörse Börse MünchenEURSymbol LLY
-
ELI LILLY & COBörse Börse FrankfurtEURSymbol LLY
-
ISIN US5324571083 WKN: 858560Symbol LLY
-
Eli Lilly and CompanyBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US532457BY33
-
Eli Lilly and CompanyBörse London Stock ExchangeISIN US532457BZ08
-
Eli Lilly and CompanyBörse BVMFISIN US532457BQ09
-
Eli Lilly and CompanyBörse Bolsa de Comercio de Buenos AiresISIN US532457BH00
-
ISIN US5324571083
Symbol LLY-WD
Währung
USD
Börse
NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Firmenname
Eli Lilly and Company
Marktkapitalisierung
162.609.462.741 (+- 19%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
178.584.305.664 oder 193.976.000.000 oder 115.268.082.559
Mitarbeiter
35.897 (+- 9%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
35.065 oder 33.625 oder 39.000 Mitarbeiter
Anzahl Aktien
956.581.598
KGV
22.62 (+- 35%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
30.54 oder 14.7
EBITDA 7.741.799.936
PEGRatio 1.1871
Buchwert 5.325
Zahlte zuletzt am 13.05.2021 eine Dividende von 0,85 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 85,67 % p. a.
beim aktuellen Kurs von 204,3 EUR +0,64%
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 204,3 EUR +0,64%
Aktionärsstruktur der Eli Lilly and Company
Portrait der Eli Lilly Aktie
Das Unternehmen Eli Lilly and Company aus USA beschäftigt 35.897 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Einzelhandel (Medikamente), Einzelhandel, Pharma tätig.
Das Unternehmen Eli Lilly and Company ist in mehr als 72 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Pharmaceutical ETF gewichtet Eli Lilly mit 5,66% im ETF.
Entdecke die 6 ETFs in denen Eli Lilly and Company am höchsten gewichtet ist Insgesamt in 72 ETFs enthalten
Dir gefallen die Informationen zu Eli Lilly?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Eli Lilly?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Eli Lilly?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Eli Lilly?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
198 News & Informationen zur Eli Lilly Aktie
Antibiotics Market Size Worth USD 64,532 Million by 2025 at 4.8% CAGR – Report by Market Research Future (MRFR)
Antibiotics Market Insights and Industry Analysis by Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), Drug Class…
Merck’s new CEO Robert Davis begins, after Ken Frazier's retirement
Robert Davis became the new chief executive officer of Merck on Thursday, one day after former CEO Ken Frazier retired.
Could Vertex Pharmaceuticals Be a Prime Acquisition Target?
It's not out of the question.
Top Biotech Companies by Market Cap
What are the biggest names in biotechnology? We count down the five top biotech companies based on market cap and share what they're up to.
PharmStars™ Reveals Leading Pharma Companies As Founding Members
BOSTON, June 30, 2021 /PRNewswire/ — PharmStars, a digital-health accelerator that launched earlier this month, announces its founding pharma members:
2 Unstoppable Stocks to Buy No Matter What Happens in the Second Half of the Year
These two pharma companies can weather whatever storm is coming our way.
Eli Lilly resolves lobbyist's sex discrimination lawsuit By Reuters
Eli Lilly resolves lobbyist's sex discrimination lawsuit
Latest Data From SURPASS Trials Demonstrate Tirzepatide Provided Meaningful Blood Sugar Reductions And Weight Loss
/PRNewswire/ — Data from the SURPASS global clinical development program for Eli Lilly and Company's tirzepatide, a novel investigational once-weekly…
Synaffix Licenses its Award-Winning ADC Technology in Deal Adding a New ADC to Innovent's Pipeline
Synaffix to provide all necessary ADC technologies, including GlycoConnect™, HydraSpace™ and one of its proprietary toxSYN™ linker-payloads Innovent to develop resulting ADC as…
Rigel Pharmaceuticals : Fostamatinib Selected for NIH ACTIV-4 COVID-19 Clinical Trial
SOUTH SAN FRANCISCO, Calif., June 29, 2021 /PRNewswire/ — Rigel Pharmaceuticals, Inc. , today announced that fostamatinib, the Company's novel oral spleen tyrosine kinase inhibitor, has been… | June 29, 2021
Fostamatinib Selected For NIH ACTIV-4 COVID-19 Clinical Trial
SOUTH SAN FRANCISCO, Calif., June 29, 2021 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that fostamatinib, the Company's novel
Fostamatinib Selected for NIH ACTIV-4 COVID-19 Clinical Trial
/PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that fostamatinib, the Company's novel oral spleen tyrosine kinase (SYK) inhibitor,…
Bajaj Healthcare zooms 20% as Co seeks compulsory licence for Baricitinib
Read more about Bajaj Healthcare zooms 20% as Co seeks compulsory licence for Baricitinib on Business Standard. The company has moved the Indian Patent Office requesting to grant a compulsory license for manufacturing & supply of Covid-19 drug “Baricitinib” (API and formulation)
Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
SAN FRANCISCO and SUZHOU, China, June 28, 2021 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical …
Bajaj Healthcare requests Indian patent office to grant compulsory licence for COVID-19 drug
The firm approached the Indian Patent Office after Eli Lilly & Company on two occasions declined to sign the voluntary licence for manufacturing and supply of COVID-19 drug Baricitinib
SLE-UPDATE Study Finds Reducing Pain, Fatigue, and Flares are Top Treatment Goals for People with Lupus
/PRNewswire/ — Findings from a study of 500 people with lupus published in Rheumatology and Therapy indicate a high level of burden with current treatments…
Empagliflozin reduced the risk of cardiovascular events and hospitalization for heart failure compared to DPP-4 inhibitors in people with type 2 diabetes
– Interim analysis of the EMPRISE real-world evidence study showed that empagliflozin was associated with a reduced risk in all-cause mortality, hospitalization for heart failure and acute kidney…
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (…
Nasdaq and S&P 500 end at record highs; Dow rallies
The Nasdaq and the S&P 500 indexes closed at record highs on Thursday, with the Dow also jumping almost 1% after U.S. President Joe Biden embraced a bipartisan Senate infrastructure deal. With massive fiscal stimulus helped the U.S. economy grow at a 6.4% annualized rate in the first quarter, investors have been banking on an infrastructure agreement that could steer the next leg of the recovery for the world's largest economy and fuel more stock gains.
$12.7 Billion Depression Drugs Global Market To 2026 – By Drug Class, Disorder Type, Drug Type, Distribution Channel And Region
DUBLIN, June 24, 2021 /PRNewswire/ — The “Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has
$12.7 Billion Depression Drugs Global Market to 2026 – by Drug Class, Disorder Type, Drug Type, Distribution Channel and Region
/PRNewswire/ — The “Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to…
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.95% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.95%
Nasdaq and S&P 500 scale new peaks; Dow rallies
The Nasdaq and the S&P 500 indexes hit all-time highs on Thursday, with the Dow also jumping, as U.S. President Joe Biden embraced a bipartisan Senate infrastructure deal. After the…
These 2 Key Themes Are Driving the Stock Market to Record Highs
Find out what you need to know about all-time highs for stocks.
Mankind Pharma Inks Distribution Pact With BDR Pharmaceuticals For COVID Drug
BDR Pharma will be manufacturing and marketing the product under a royalty free, limited and non-exclusive voluntary license from Eli Lilly and Company., , mankind pharma, ECMO, Covid treatment, BDR Pharmaceuticals, FMCG brands
Apple, Lilly, Take-Two Interactive, Roku and More Thursday Afternoon Analyst Research Calls – 24/7 Wall St.
Here's a look at the latest analyst calls for Thursday, June 24.
Nasdaq, S&P 500 scale new peak as weekly jobs recovery gains traction
Read more about Nasdaq, S&P 500 scale new peak as weekly jobs recovery gains traction on Business Standard. Tesla shares boost Nasdaq, S&P 500; Lilly jumps on plans to seek approval for Alzheimer's drug
PreMarket Prep Recap: The 4 Stocks Dennis Dick Bought Yesterday
On Wednesday’s PreMarket Prep, co-hosts Joel Elconin and Dennis Dick discussed the bullish chart setups in several tech stocks.
…
Nasdaq, S&P 500 scale new peak as jobs recovery gains traction
The Nasdaq and the S&P 500 indexes hit all-time highs on Thursday, boosted by shares of Tesla and other top-shelf technology firms as data showing fewer weekly jobless claims bolstered views…
CIO Leadership: Cultivating a Connected Culture That Embraces Diversity, Equity & Inclusion Will Power the Discussion at the 2021 HMG Live! Financial Services CIO Executive Leadership Summit on June 3
WESTPORT, Conn., June 24, 2021 — HMG Strategy, the World’s #1 digital platform for enabling technology executives to reimagine the enterprise and reshape the business world, is…
Lilly announces call for Leonard Award nominations as part of global initiative celebrating 100 years of insulin
/PRNewswire/ — In honor of the 100th anniversary of the discovery of insulin, Eli Lilly and Company (NYSE: LLY) today launched the Leonard Award to recognize…
Mankind Pharma inks distribution pact with BDR Pharma for Covid drug
Read more about Mankind Pharma inks distribution pact with BDR Pharma for Covid drug on Business Standard. Delhi-based Mankind Pharma operates in 34 overseas destinations.
Lilly's donanemab receives U.S. FDA's Breakthrough Therapy designation for treatment of Alzheimer's disease
INDIANAPOLIS, June 24, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for donanemab, El…
Active Pharmaceutical Ingredient Market Revenue To Reach ~$300 Billion by 2030: P&S Intelligence
/PRNewswire/ — The global active pharmaceutical ingredient (API) market is set for rapid expansion in the coming years, primarily because of the increasing…
Amunix Appoints Industry Veteran, Frank Watanabe, to its Board of Directors
SOUTH SAN FRANCISCO, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Amunix Pharmaceuticals, Inc. (“Amunix”), an immuno-oncology company leveraging its…
Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer
Press Release Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer Copenhagen and Aarhus, Denmark, 23 June 2021 – Draupnir Bio (“Draupnir”),…
AbCellera selects Vancouver site for new 130k-sq-ft manufacturing plant
AbCellera Biologics Inc. (Nasdaq:ABCL) is set to further expand its footprint in Vancouver after selecting a site in the city’s east side for a manufacturing plant.
BioCorRx Welcomes Four Experts to Expanded Scientific Advisory Board
ANAHEIM, CA, June 22, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of…
Dual-antibody drugs effective against COVID-19 variants in animal study By Reuters
Dual-antibody drugs effective against COVID-19 variants in animal study
Rising Diabetic Patients Pool Prompts High Demand for Smart Insulin Pens, Market Estimated to be valued at US$ 70.4 Mn by 2027 End: TMR
/PRNewswire/ — Smart insulin refers to advanced insulin that is capable to respond automatically to varying blood glucose levels. Thus, higher or lower blood…